Ryman Healthcare Limited

RHCGFOTCHealthcare● Active

$1.41

+$0.00(+0.00%)

Market Cap$1.4B

P/E Ratio—

52W High$3.11

52W Low$1.21

Avg Volume35.82

Open$1.41

Beta0.35

Free Cash Flow Financials Revenue

Ryman Healthcare Limited (RHCGF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

RHCGF · free cash flow · updated Jun 9, 2026

Core FCF metrics

RHCGF · FCF · TTM · margin & CAGR

Free cash flow was $275.1M for FY2026 (fiscal year ending 2026-03-31), down 9.2% year-over-year The FCF margin was 34.1%. Five-year CAGR stands at +13.3%.

FY2026 Free Cash Flow$275.1M▼ -9.2% YoY

Trailing 12M (TTM)$527.2Mtrailing 4 quarters sum

FCF Margin34.1%$275.1M ÷ revenue

3-Year CAGR+8.0%FY2023 → FY2026

5-Year CAGR+13.3%FY2021 → FY2026

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

RHCGF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2026Latest$322.9M(48M)$275.1M▼ 9.2%34.1%

FY2025$410.3M(107M)$302.9M▼ 37.7%42.4%

FY2024$658.5M(172M)$486.3M▲ +122.5%74.8%

FY2023$542.8M(324M)$218.6M▼ 7.9%39.0%

FY2022$536.0M(299M)$237.3M▲ +61.4%47.1%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

RHCGF · P/FCF · FCF yield · FCF per share

Ryman Healthcare Limited (RHCGF) trades at a FCF yield of 11.81% and a price-to-free-cash-flow ratio of 2.7x. FCF per share stands at $0.52, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

11.81%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.52

TTM FCF ÷ Shares Outstanding

Price / FCF

x2.7

Share Price ÷ FCF per Share

EV / FCF (TTM)

x14.3

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2026 · 2026-03-31

Cash flow statement summary

RHCGF · cash flow statement · operating / investing / financing

For FY2026, Ryman Healthcare Limited generated $322.9M in operating cash flow and spent 48M in capital expenditures, yielding $275.1M in free cash flow.

Operating Activities

+$322.9M

Cash from core business operations

2026-03-31

Investing Activities

−$134.7M

CapEx, acquisitions & investments

2026-03-31

Financing Activities

−$196.5M

Buybacks, dividends & debt

2026-03-31

FCF FormulaOperating CF ($322.9M) − |CapEx| (48M) = FCF ($275.1M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

RHCGF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Ryman Healthcare LimitedYOU

RHCGF

$275.1M-9.2%34.1%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Ryman Healthcare Limited (RHCGF) reported free cash flow of $275.1M for FY2026 (fiscal year ending 2026-03-31), down 9.2% year-over-year. The FCF margin was 34.1%.

Based on available data, Ryman Healthcare Limited has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $486.3M in FY2024. The 5-year CAGR stands at +13.3%.

Ryman Healthcare Limited's FCF yield is 11.81% and price-to-FCF ratio is 2.7x for FY2026, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

RHCGF free cash flow · 8 questions

Ryman Healthcare Limited free cash flow was $275.1M for FY2026, down 9.2% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $527.2M.

RHCGF free cash flowRHCGF FCFRHCGF FCF 2026RHCGF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Ryman Healthcare Limited · Ryman Healthcare Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026